Episode Details

Back to Episodes
Four-Year Weight Loss with Wegovy (Semaglutide 2.4mg) Cardiovascular Study - Part 1

Four-Year Weight Loss with Wegovy (Semaglutide 2.4mg) Cardiovascular Study - Part 1

Published 2 years, 2 months ago
Description

As you might imagine, I subscribe to a large number of medical publications and in the last couple of days I’ve been receiving updates from them falling all over themselves to breathlessly claim that weight loss was maintained for 4 years on Semaglutide 2.4mg (aka Wegovy) in the SELECT trial.

The ways in which these claims are misleading are egregious and anti-science. In part 1 I’ll look at the initial claims and the people making them, in part 2 I’ll do a deeper analysis of the study.



Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us